SCHEMBL20205446

SCHEMBL20205446

Cc1cc(C)cc(-c2cc3c(c4oc5ccccc5c24)-c2cc4c(cc2C3(C)C)-c2c(cc(-c3cc(C)cc(C)c3)c3c2oc2ccccc23)C4(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 2/20 0.36
▸ BRD9 Q9H8M2 1/20 0.35
▸ BRD7 Q9NPI1 1/20 0.35
▸ MAOA P21397 1/20 0.33
▸ ALK Q9UM73 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ MAOB P27338 2/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TNKS O95271 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ TNKS2 Q9H2K2 1/20 0.32
▸ PARP2 Q9UGN5 1/20 0.32
▸ ALOX5 P09917 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ MAPT P10636 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205404 0.90 PGR (0.36) PGRBRD9BRD7MAOAALK
SCHEMBL20205307 0.88 CDC14B (0.39) PGRALKALDH1A1ALOX15TSHR
SCHEMBL20205319 0.88 CDC14B (0.34) PGRMAOAALKALDH1A1TSHR
SCHEMBL20205386 0.86 MAPT (0.33) PGRALKTNKSPARP1TNKS2
SCHEMBL20205313 0.86 CDC14B (0.38) PGRALKALDH1A1ALOX15TSHR
SCHEMBL20205320 0.85 CDC14B (0.37) PGRALKALDH1A1ALOX15TSHR
SCHEMBL20205723 0.84 ALOX5 (0.36) PGRALKALOX5
SCHEMBL20205549 0.84 ALOX5 (0.36) PGRALKALOX5
SCHEMBL20205709 0.84 CDC14B (0.33) PGRALKTNKSPARP1TNKS2
SCHEMBL20205309 0.84 PLA2G2A (0.36) PGRALDH1A1TNKSPARP1TNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PGR 4271/4885BRD9 27/4885BRD7 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback